Back to results
US 10,080,805 B2Granted
Cholecystokinin B receptor targeting for imaging and therapy
AssigneePurdue Research Foundation
InventorsPhilip S. Low, Charity Wayua
Life of this patent
Estimating the term…
Abstract
Conjugates are described herein where CCK2R targeting ligands are attached to an active moiety, such as therapeutic agent or an imaging agent, through a linker. The conjugates can be used in the detection, diagnosis, imaging and treatment of cancer.
Claims1
A conjugate of formula
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.